La Jolla Pharmaceutical Co.

+0.08 (+2.14%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)105.01M
Current PE36.05
Forward PE 7.49
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$12.1 Million
Adjusted EPS-$0.07
See more estimates
10-Day MA$3.84
50-Day MA$4.01
200-Day MA$4.53
See more pivots

La Jolla Pharmaceutical Co. Stock, NASDAQ:LJPC

201 Jones Road, Suite 400, Waltham, Massachusetts 02451
United States of America
Phone: +1.617.715.3600
Number of Employees: 59


La Jolla Pharmaceutical Co. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases. Its products portfolio include GIAPREZA and XERAVA. The company was founded in 1989 and is headquartered in San Diego, CA.